Chong Kun Dang Pharmaceutical Corp. (185750.KS)
KRW 91600.0
(-0.76%)
KRW 91600.0
(-0.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 318.15 Billion | 67.73 Billion | 12.9 Billion | 104.32 Billion | 77.29 Billion | 42.62 Billion |
| Net Income | 212.52 Billion | 79.97 Billion | 42.35 Billion | 90.4 Billion | 52.97 Billion | 41.7 Billion |
| Depreciation & Amortization | 36.94 Billion | 33.59 Billion | 27.48 Billion | 23.78 Billion | 23.05 Billion | 21.21 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 29.68 Billion | -77.29 Billion | -71.56 Billion | -51.48 Billion | -21.55 Billion | -41.43 Billion |
| Other non-cash items | 39.01 Billion | 31.45 Billion | 14.63 Billion | 41.61 Billion | 22.81 Billion | 21.14 Billion |
| Investing Cash Flow | -171.31 Billion | -65.38 Billion | -90.8 Billion | -63.92 Billion | -39.72 Billion | -30.33 Billion |
| Investments in PPE | -68.8 Billion | -53.06 Billion | -51.84 Billion | -36.81 Billion | -24.86 Billion | -24.64 Billion |
| Acquisitions | 451.58 Million | 142.13 Million | -3.44 Billion | -4.1 Billion | -2.69 Billion | 509.43 Million |
| Investment purchases | -192.46 Billion | -57.18 Billion | -61.26 Billion | -59.95 Billion | -17.05 Billion | -6.2 Billion |
| Sales/Maturities of investments | 89.47 Billion | 44.37 Billion | 21.93 Billion | 32.51 Billion | 1.8 Billion | - |
| Other Investing Activities | 39.75 Million | 347.81 Million | 3.81 Billion | 4.44 Billion | 3.07 Billion | 509.42 Million |
| Financing Cash Flow | -43.69 Billion | -16.33 Billion | 85.13 Billion | 7.06 Billion | -6.58 Billion | -11.73 Billion |
| Debt repayment | -22.71 Billion | -263.14 Thousand | -896.23 Million | -61.96 Billion | -11.83 Billion | -75.03 Billion |
| Dividends payments | -11.6 Billion | -11.23 Billion | -10.8 Billion | -9.27 Billion | -8.83 Billion | -8.46 Billion |
| Common Stock Repurchased | -6.02 Billion | -1.88 Billion | -1.93 Billion | -2.07 Billion | -442.89 Million | -6.95 Billion |
| Common Stock Issuance | -3.33 Billion | - | - | - | - | 1.35 Billion |
| Other Financing Activities | -16.53 Million | -3.21 Billion | 98.77 Billion | 80.39 Billion | 14.52 Billion | 77.35 Billion |
| Accounts receivables | -29.55 Billion | -51.43 Billion | -6.92 Billion | -21.89 Billion | 10.83 Billion | -1.07 Billion |
| Accounts payables | 38.58 Billion | 15.82 Billion | -15.59 Billion | 42.35 Billion | 33.4 Billion | -2.57 Billion |
| Inventory | -5.98 Billion | -54.46 Billion | -53.77 Billion | -46.24 Billion | -48.84 Billion | -30.8 Billion |
| Other working capital | 26.63 Billion | 12.77 Billion | 4.72 Billion | -25.7 Billion | -16.94 Billion | -10.63 Billion |
| Cash at beginning of period | 117.41 Billion | 131.81 Billion | 123.65 Billion | 76.92 Billion | 45.94 Billion | 45.47 Billion |
| Cash at end of period | 219.64 Billion | 117.41 Billion | 131.81 Billion | 123.65 Billion | 76.92 Billion | 45.94 Billion |
| Capital Expenditure | -68.8 Billion | -53.06 Billion | -51.84 Billion | -36.81 Billion | -24.86 Billion | -24.64 Billion |
| Effect of forex changes on cash | -917.57 Million | -410.12 Million | 920.09 Million | -734.86 Million | -1.88 Million | -78.28 Million |
| Net cash flow / Change in cash | 102.22 Billion | -14.39 Billion | 8.15 Billion | 46.73 Billion | 30.97 Billion | 477.47 Million |
| Free Cash Flow | 249.35 Billion | 14.66 Billion | -38.94 Billion | 67.5 Billion | 52.42 Billion | 17.98 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 53.36 Billion | 25.57 Billion | 88.25 Billion | 212.52 Billion | 46.23 Billion | 43.16 Billion |
| Depreciation & Amortization | 9.53 Billion | 9.37 Billion | 9.07 Billion | 36.94 Billion | 9.52 Billion | 9.27 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -90.34 Billion | -1.51 Billion | 20.32 Billion | 29.68 Billion | 22.51 Billion | -8.5 Billion |
| Other non-cash items | 13.82 Billion | 17.18 Billion | 23.54 Billion | 39.01 Billion | 6.45 Billion | 5.74 Billion |
| Investing Cash Flow | 24.96 Billion | -45.99 Billion | -140.32 Billion | -171.31 Billion | 10.73 Billion | -35.49 Billion |
| Investments in PPE | -5.74 Billion | -14.23 Billion | -18.53 Billion | -68.8 Billion | -10.68 Billion | -28.47 Billion |
| Acquisitions | 1.33 Million | 32 Million | -31.6 Million | 451.58 Million | 3.27 Billion | 17.39 Billion |
| Investment purchases | -137.44 Billion | -130.64 Billion | -168.96 Billion | -192.46 Billion | -5.73 Billion | -17.47 Billion |
| Sales/Maturities of investments | 180.6 Billion | 98.7 Billion | 47.17 Billion | 89.47 Billion | 26.92 Billion | 10.25 Billion |
| Other Investing Activities | 30.71 Billion | 145.78 Million | 39.75 Million | 39.75 Million | -3.03 Billion | -17.19 Billion |
| Financing Cash Flow | -20.62 Billion | -7.18 Billion | -6.02 Billion | -43.69 Billion | -15.7 Billion | -18.61 Billion |
| Debt repayment | -1.22 Billion | -2.52 Billion | -835.22 Million | -22.71 Billion | -24.87 Billion | -18.17 Billion |
| Dividends payments | -13.33 Billion | - | - | -11.6 Billion | - | -11.6 Billion |
| Common Stock Repurchased | -6.04 Billion | -3.85 Billion | -4.32 Billion | -6.02 Billion | - | - |
| Common Stock Issuance | - | - | - | -3.33 Billion | - | - |
| Other Financing Activities | -17.79 Million | 2.42 Million | -864.63 Million | -16.53 Million | 9.16 Billion | 11.17 Billion |
| Accounts receivables | -22.38 Billion | 35.8 Billion | -20.59 Billion | -29.55 Billion | -18.29 Billion | 3.39 Billion |
| Accounts payables | 47.07 Billion | -535.04 Million | -12.26 Billion | 38.58 Billion | 54.08 Billion | -11.8 Billion |
| Inventory | -62.5 Billion | -21.61 Billion | 14.04 Billion | -5.98 Billion | -3.01 Billion | -3.37 Billion |
| Other working capital | -5.45 Billion | -15.16 Billion | 39.13 Billion | 26.63 Billion | -10.27 Billion | 3.28 Billion |
| Cash at beginning of period | 213.62 Billion | 219.64 Billion | 226.04 Billion | 117.41 Billion | 146.15 Billion | 150.88 Billion |
| Cash at end of period | 205.07 Billion | 213.62 Billion | 219.64 Billion | 219.64 Billion | 226.04 Billion | 146.15 Billion |
| Capital Expenditure | -5.74 Billion | -14.23 Billion | -18.53 Billion | -68.8 Billion | -10.68 Billion | -28.47 Billion |
| Effect of forex changes on cash | 724.05 Million | 1.63 Billion | -1.25 Billion | -917.57 Million | 132.98 Million | -302.66 Million |
| Net cash flow / Change in cash | -8.55 Billion | -6.02 Billion | -6.4 Billion | 102.22 Billion | 79.89 Billion | -4.72 Billion |
| Free Cash Flow | -19.36 Billion | 31.28 Billion | 122.65 Billion | 249.35 Billion | 74.04 Billion | 21.2 Billion |
9502
2505
TITC
QLYS
1904
6168